Einav Gal Yam - Sheba Medical Center

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 20 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

BREAst Cancer Personalized NuTrition (BREACPNT): Dietary Intervention in HR Plus Breast Cancer Patients Treated with Endocrine Therapy

Michal Rein,Maya Dadiani,Anastasia Godneva,Michal Bakalenik-Gavry,Dana Morzaev-Sulzbach,Maya Lotan-Pompan,Adina Weinberger,Eran Segal,Einav Gal-Yam

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Adding Atezolizumab to Adjuvant Chemotherapy for Stage II and III Triple-Negative Breast Cancer is Unlikely to Improve Efficacy: Interim Analysis of the ALEXANDRA/IMpassion030 Phase 3 Trial

Michail Ignatiadis,Andrew Bailey,Heather McArthur,Sarra El-Abed,Evandro de Azambuja,Otto Metzger, Steve Chui, Max Dieterich, Thomas Perretti,Guenther Steger,Jacek Jassem,Soo Chin Lee,Michaela Higgins, Jose Zarba,Marcus Schmidt,Henry Gomez,Angel Guerrero-Zotano,Luca Moscetti,Joanne Win Yang Chiu,Carter DuFrane,Vanessa Honvault, Rosa Altarcheh,Luciana Molinero, Andrew Ellingson,Elisabetta Munzone, Noa Efrat Ben-Baruch,Emilio Bajetta,Shinji Ohno, Seock-Ah Im,Gustavo Werutsky,Einav Gal-Yam, Xavier Gonzalez-Farre,Ling-Ming Tseng,William Jacot,Oleg Gluz,Zhimin Shao,Yaroslav Shparyk, Ivan Sinielnikov,Zimina Anastasia, Aleksandr Vasiliev, Esther Shearer-Kang,Eric Winer,Diogo Martins-Branco,Shona Fielding,David Cameron,Giuseppe Viale,Shigehira Saji,Richard Gelber,Martine Piccart

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Abstract PS17-04: Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches

Cancer Researchno. 9_Supplement (2024): PS17-04

引用0浏览0引用

The Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Expression by RT-PCR on Tumor Characteristics and Outcome in Estrogen Receptor (ER) Positive, HER2 Negative Early-Stage Breast Cancer

Hadar Goldvaser,Raz Mutai,Salomon Stemmer,Iryna Kuchuk,Margarita Tokar,Shani Paluch-Shimon, Rinat Yerushalmi,Karen Drumea,Ella Evron,Amir Sonnenblick,Einav Gal-Yam, Gil Bar Sela,Ayelet Shai,Rotem Merose,Avital Bareket-Samish,Lior Soussan-Gutman

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

ER + HER2- Early-Stage Breast Cancer: Association of HER2 Expression, Tumor Characteristics, and Outcomes

Hadar Goldvaser,Rinat Yerushalmi,Raz Mutai,Iryna Kuchuk, Margarita Toker,Shani Paluch-Shimon,Karen Drumea,Ella Evron,Amir Sonnenblick,Einav Gal-Yam,Gil Bar- Sela,Ayelet Shai,Rotem Merose,Avital Bareket-Samish,Lior Soussan-Gutman,Salomon M. Stemmer

Breast Cancer Research and Treatmentpp.1-11, (2024)

引用0浏览0WOS引用

Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Abstract PO5-01-08: the Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Expression by RT-PCR on Tumor Characteristics and Outcome in Estrogen Receptor (ER) Positive, HER2 Negative Early-Stage Breast Cancer

Hadar Goldvaser,Raz Mutai,Salomon Stemmer,Iryna Kuchuk,Margarita Tokar,Shani Paluch-Shimon,Rinat Yerushalmi,Karen Drumea,Ella Evron,Amir Sonnenblick,Einav Gal-Yam,Gil Bar Sela,Ayelet Shai,Rotem Merose,Avital Bareket-Samish,Lior Soussan-Gutman

Cancer Researchno. 9_Supplement (2024): PO5-01

引用0浏览0引用

Supplementary Table S7 from Olaparib Plus Durvalumab, with or Without Bevacizumab, As Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study

Yvette Drew, Jae-Weon Kim, Richard T. Penson,David M. O'Malley,Christine Parkinson,Patricia Roxburgh,Ruth Plummer, Seock-Ah Im,Martina Imbimbo,Michelle Ferguson,Ora Rosengarten,Neeltje Steeghs, Min Hwan Kim,Einav Gal-Yam,Daliah Tsoref, Jae-Hoon Kim, Benoit You,Maja De Jonge,Roy Lalisang,Eelke Gort,Sara Bastian,Kassondra Meyer,Laura Feeney,Nigel Baker, Mei-Lin Ah-See, Susan M. Domchek, Susana Banerjee

openalex（2024）

引用0浏览0引用

Abstract PO2-02-02: BREAst Cancer Personalized NuTrition (BREACPNT): Dietary Intervention in HR+ Breast Cancer Patients Treated with Endocrine Therapy

Michal Rein,Maya Dadiani,Anastasia Godneva,Michal Bakalenik-Gavry,Dana Morzaev-Sulzbach,Maya Lotan-Pompan,Adina Weinberger,Eran Segal,Einav Gal-Yam

Cancer Researchno. 9_Supplement (2024): PO2-02

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn